MedPath

Calfactant for Direct Acute Respiratory Distress Syndrome

Phase 3
Terminated
Conditions
Respiratory Distress Syndrome, Adult
Interventions
Drug: Room Air (placebo)
Drug: Calfactant
Registration Number
NCT00682500
Lead Sponsor
Pneuma Pharmaceuticals Incorporated
Brief Summary

This study will determine if administration of an suspension of calfactant, a lung surfactant, intratracheally in patients with Direct Acute Respiratory Distress Syndrome within 48 hours of requiring mechanical ventilation can decrease the mortality in patients with lethal disease and shorten the course of respiratory failure in patients with sub-lethal disease.

Detailed Description

Recruitment limited to direct adult respiratory distress syndrome patients who have been intubated \<48 hours. Origin of ARDS must be infectious pneumonia, aspiration of stomach contents, near drowning, smoke inhalation without pulmonary burn, inhaled industrial gas.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
332
Inclusion Criteria
  1. Respiratory failure due to diffuse infectious pneumonia, aspiration, near drowning, smoke inhalation or industrial gas
  2. Less than 48 hours of mechanical ventilation
  3. Informed consent
Read More
Exclusion Criteria
  1. Pre-existing lung disease
  2. coma
  3. limited therapeutic goals (do not resuscitate, etc.)
  4. failure of another vital organ
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
2Room Air (placebo)-
1CalfactantCalfactant treatment
Primary Outcome Measures
NameTimeMethod
Mortality Rate90 days
Secondary Outcome Measures
NameTimeMethod
Duration of mechanical ventilation90 days

Trial Locations

Locations (32)

Royal Columbian Hospital

🇨🇦

New Westminster, British Columbia, Canada

Surrey Memorial Hospital

🇨🇦

Vancouver, British Columbia, Canada

Dartmouth-Hitchcock Medical Center

🇺🇸

Lebanon, New Hampshire, United States

Vancouver General Hospital

🇨🇦

Vancouver, British Columbia, Canada

Uthscsa/Stvah

🇺🇸

San Antonio, Texas, United States

Northwestern University-Chicago

🇺🇸

Chicago, Illinois, United States

Clarian Health, Inc/Methodist Hospital

🇺🇸

Indianapolis, Indiana, United States

University of Iowa

🇺🇸

Iowa City, Iowa, United States

British Columbia Children's Hospital

🇨🇦

Vancouver, British Columbia, Canada

Columbia Medical Center--Pediatrics

🇺🇸

New York, New York, United States

Royal Adelaide Hospital

🇦🇺

Adelaide, South Australia, Australia

Auckland City Hospital

🇳🇿

Auckland City, Auckland, New Zealand

Rabin Medical Center

🇮🇱

Jerusalem, Israel

Kingston General Hospital

🇨🇦

Kingston, Ontario, Canada

London Health Sciences Centre

🇨🇦

London, Ontario, Canada

Ottawa Hospital

🇨🇦

Ottawa, Ontario, Canada

Haemek Medical Center

🇮🇱

Jerusalem, Israel

University of Florida

🇺🇸

Gainesville, Florida, United States

Peoria Pulmonary Associates/OSF St. Francis Hospital

🇺🇸

Peoria, Illinois, United States

Penn State University

🇺🇸

Hershey, Pennsylvania, United States

INOVA Fairfax Hospital

🇺🇸

Fairfax, Virginia, United States

University of Virginia Health Science Center

🇺🇸

Charlottesville, Virginia, United States

West Suburban Hospital Medical Center

🇺🇸

Oak Park, Illinois, United States

Baylor College of Medicine/Texas Children's Hospital

🇺🇸

Houston, Texas, United States

Starship Children's Hospital

🇳🇿

Auckland, New Zealand

Asan Medical Center

🇰🇷

Seoul, Korea, Republic of

Samsung Medical Center

🇰🇷

Seoul, Korea, Republic of

Creighton University

🇺🇸

Omaha, Nebraska, United States

The Oregon Clinic

🇺🇸

Portland, Oregon, United States

Florida Hospital and Florida Children's Hospital

🇺🇸

Orlando, Florida, United States

Omaha Children's Hospital

🇺🇸

Omaha, Nebraska, United States

Medical College of Wisconsin

🇺🇸

Milwaukee, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath